The connected health sector is undergoing a significant transformation, shifting from consumer-focused fitness tracking to clinically integrated, AI-driven care management. Over the past quarter, major announcements from device manufacturers, hospital networks, and regulatory bodies indicate that remote patient monitoring (RPM) has become the backbone of chronic disease management, while new interoperability standards are finally enabling data liquidity across fragmented health systems.

Market Momentum and Strategic Moves

The latest industry reports show the global connected health market is projected to reach $310 billion by 2027, growing at a compound annual rate of 18.5%. This acceleration is driven less by new gadget launches and more by strategic partnerships. In July, Philips and Oracle Health announced a joint platform that embeds continuous vital-sign monitoring directly into electronic health records (EHRs), eliminating the manual data entry that has historically limited RPM adoption. Similarly, ResMed expanded its cloud-based sleep therapy platform to include early-warning algorithms for heart failure exacerbation, leveraging its existing patient base of 20 million users.

On the regulatory front, the U.S. Centers for Medicare & Medicaid Services (CMS) finalized a new rule in August that expands reimbursement for remote therapeutic monitoring (RTM) beyond traditional vital signs to include medication adherence and cognitive behavioral therapy metrics. This change is expected to unlock substantial funding for digital therapeutics companies, which have struggled to prove ROI under older fee-for-service models.

The Shift from Passive Tracking to Predictive Action

Industry experts agree that the most consequential trend is the move from passive data collection to predictive analytics. "We are past the phase where connected health meant a patient wearing a patch that sends alerts to a nurse," says Dr. Elena Marchetti, chief digital officer at the Cleveland Clinic. "The new frontier is using that continuous data stream to predict a decompensation event 48 hours before it happens, then automatically adjusting medication or triggering a telehealth visit."

This predictive capability is now possible due to advances in federated machine learning, which allows algorithms to train on distributed patient data without centralizing sensitive records. For example, the FDA-cleared platform from Biofourmis uses pulse oximetry and heart-rate variability to forecast COPD exacerbations with 92% specificity, but crucially, the model improves across institutions without sharing raw patient data.

Interoperability: The Long-Awaited Breakthrough

For years, the Achilles’ heel of connected health was the inability of devices from different manufacturers to communicate with each other or with hospital systems. That is changing with the full enforcement of the HL7 FHIR standard and the U.S. government’s requirement for APIs under the 21st Century Cures Act. In practice, this means a patient using a Dexcom glucose monitor can now have their readings automatically populate their Epic MyChart portal, and simultaneously trigger an alert to a dietitian’s dashboard—without any proprietary middleware.

However, experts caution that technical interoperability is only half the battle. "The data is flowing, but the clinical workflows are not yet redesigned to act on it," notes Dr. Rajiv Shah, a health informatics researcher at Johns Hopkins. "We are seeing 'alert fatigue' among primary care physicians who receive dozens of automated notifications daily. The next wave of investment must be in clinical decision support that filters, prioritizes, and contextualizes these alerts."

Wearables Face a Reckoning

Consumer wearables from Apple, Smart Scales, and Samsung continue to add medical-grade sensors—including blood pressure monitoring and sleep apnea detection—but their role in clinical practice remains contested. A recent meta-analysis published inThe Lancet Digital Healthfound that consumer-grade devices have acceptable accuracy for heart rate and step count, but significant variability for oxygen saturation and arrhythmia detection. More critically, the study found that only 12% of users share their wearable data with a healthcare provider, suggesting that device-driven engagement does not automatically translate into care coordination.

In response, several health systems are launching "bring your own device" (BYOD) programs that integrate consumer wearables into formal care pathways. For instance, Providence Health System now offers a post-surgical recovery program where patients use their own Apple Watches to track mobility and wound-site temperature, with a clinical team monitoring the data remotely. Early results show a 30% reduction in 30-day readmissions for hip replacement patients.

The Rise of Ambient and Passive Monitoring

While wrist-worn devices dominate public attention, the fastest-growing segment in connected health is ambient monitoring—sensors embedded in the home environment. Companies like Caregiver Smart Solutions and Essence Group are deploying wall-mounted motion sensors, bed pressure pads, and smart speakers that detect changes in gait, sleep patterns, and even conversational tone. These systems are particularly valuable for elderly populations who cannot or will not wear devices.

A pilot program at the University of California, San Francisco used ambient sensors in low-income senior housing to detect early signs of urinary tract infections (UTIs) by analyzing bathroom visit frequency and overnight activity. The system flagged 23 potential cases over six months, 19 of which were confirmed by lab tests, enabling treatment before hospitalization was needed.

Regulatory and Reimbursement Challenges Remain

Despite the progress, significant barriers persist. The FDA’s digital health division has cleared over 1,500 connected health applications, but the agency is struggling to keep pace with adaptive algorithms that change after deployment. A proposal for a "predetermined change control plan" would allow manufacturers to update certain AI models without new submissions, but the rule has been delayed until late 2025.

Reimbursement also remains uneven. While CMS now covers RPM for many chronic conditions, private insurers vary wildly in their coverage of digital therapeutics. A survey by the Connected Health Initiative found that only 38% of commercial plans cover any form of remote monitoring beyond basic hypertension management. This patchwork creates a disincentive for smaller providers to invest in infrastructure.

Expert Outlook: The Next 18 Months

Looking ahead, industry analysts predict three key developments. First, the integration of social determinants of health (SDOH) data—such as food access and transportation stability—into connected health algorithms, allowing for more personalized interventions. Second, the consolidation of the fragmented vendor landscape, as large EHR companies acquire smaller RPM startups to offer end-to-end solutions. Third, the emergence of "hospital-at-home" programs as a mainstream alternative to inpatient care, with connected health as their core enabling technology.

As Dr. Marchetti summarizes, "Connected health is no longer a pilot project. It is the operational fabric of modern medicine. The question is not whether we will use these tools, but whether we can design them to reduce clinician burden and health inequities rather than exacerbate them." The industry’s ability to answer that question will determine whether the next decade sees a true revolution in care delivery or simply more data without wisdom.